United States · FDA National Drug Code directory

Relispray Antifungal Liquid

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
46063-810_fc49d7c5-107d-4fa8-be6c-dca84e98ece2
Product NDC
46063-810
Form
AEROSOL, SPRAY
Composition / generic term
Tolnaftate
Labeler
Midas-Care Pharmaceuticals Pvt. Ltd.
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20220301
Source listing expiry
20261231

Source-listed ingredients

  • TOLNAFTATE — .01 g/g

These values do not establish equivalence or a dose recommendation.

Packages

  • 128 g in 1 CAN (46063-810-12) · 46063-810-12

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Relispray Antifungal Liquid — United States | Molindra Medicines